DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on August 27, 2026

Aug. 27, 2026

Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure

Indeterminate GlobeNewswire

Aug. 27, 2026

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

Indeterminate GlobeNewswire

Aug. 27, 2026

As AI Data Center Investment Surges, New Tracker Gives Developers and Investors a Real-Time View of Media Risk Across U.S. Markets

Indeterminate GlobeNewswire

Aug. 27, 2026

Clearsense CEO Jason Rose to Join KLAS DHIS Panel on Unlocking Value Across the Data Lifecycle

Indeterminate GlobeNewswire

Aug. 27, 2026

TECfusions Announces New Kensington Data Center is Live, Delivering GPU Capacity and Responsible On-Site Power Plan

Indeterminate GlobeNewswire

Aug. 27, 2026

ROC Secures Landmark Five-Year $5.1 Million Federal ABIS Contract

Indeterminate GlobeNewswire

Aug. 27, 2026

Airia Advances MCP Gateway With Intelligent Routing and Enterprise Access Controls

Indeterminate GlobeNewswire

Aug. 27, 2026

Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting

Indeterminate GlobeNewswire

Aug. 27, 2026

Synack to Present on AI Pentesting and Human Validation at BrightTALK Summit

Indeterminate GlobeNewswire

Aug. 27, 2026

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Indeterminate GlobeNewswire

Aug. 27, 2026

Genius Group Announces $1.2 Billion Capital Plan to Fund AI Treasury and Bitcoin Treasury

Indeterminate GlobeNewswire

Aug. 27, 2026

Entera to Participate in Upcoming Fall Investor Conferences

Indeterminate GlobeNewswire

Aug. 27, 2026

Eascra Biotech Awarded $7.96 Million NASA InSPA Phase 2 Contract to Advance Space-Manufactured Nanomedicine

Indeterminate GlobeNewswire

Aug. 27, 2026

Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push

Indeterminate GlobeNewswire

Aug. 27, 2026

Grants Restricted Share Units to Darren Wolfe Director Sales, Federal & Public Safety

Indeterminate GlobeNewswire

Aug. 27, 2026

Xtract One Technologies Selected by Metro Toronto Convention Centre to Enhance Security for World-Class Events

Indeterminate GlobeNewswire

Aug. 27, 2026

BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

Indeterminate GlobeNewswire

Aug. 27, 2026

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

Indeterminate GlobeNewswire

Aug. 27, 2026

3D Systems Launches Partnership with Savannah River National Laboratory to Advance 3D Printing for Advanced Energy and National Security Applications

Indeterminate GlobeNewswire

Aug. 27, 2026

Veea and Telarus Sign Technology Services Distribution Agreement to Expand Access to Secure, Intelligent Connectivity Solutions

Indeterminate GlobeNewswire